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ABSTRACT
The N-terminal tail of histone H2B is believed to
be involved in gene silencing, but how it exerts its
function remains elusive. Here, we report the
biochemical characterization of p14ARF tumor sup-
pressor as a transcriptional repressor that select-
ively recognizes the unacetylated H2B tails on
nucleosomes. The p14ARF–H2B tail interaction is
functional, as the antagonistic effect of p14ARF on
chromatin transcription is lost upon deletion or
acetylation of H2B tails. Gene expression profiling
and chromatin immunoprecipitation studies empha-
size the significance of H2B deacetylation and
p14ARF recruitment in establishing a repressive en-
vironment over the cell cycle regulatory genes.
Moreover, HDAC1-mediated H2B deacetylation, es-
pecially at K20, constitutes an essential step in
tethering p14ARF near target promoters. Our
results thus reveal a hitherto unknown role of
p14ARF in the regulation of chromatin transcription,
as well as molecular mechanisms governing the
repressive action of p14ARF.
INTRODUCTION
In eukaryotic cells, DNA is hierarchically packaged into a
highly organized structure of chromatin by means of
stable association with histones H2A, H2B, H3 and H4.
The repeating unit of chromatin is the nucleosome, which
comprises 147bp of DNA spooled around a histone
octamer (1,2). The most dynamic parts of the nucleosome
are unstructured amino-terminal domains (called histone
‘tails’) of core histones that mediate contacts between
adjacent nucleosomes and interact with chromatin-
associated proteins (3–5). One H3–H4 tetramer organizes
the central part of the nucleosome by interacting with
 80bp DNA around the dyad, whereas two H2A–H2B
dimers each bind to  30bp DNA lying at the peripheral
part of the nucleosome (2,6,7). Based on this unique struc-
ture of the nucleosome, the past decades of studies mainly
focused on H3 and H4 tails as a major arbiter of chroma-
tin transcription, with relatively little attention paid to a
possible role of H2A and H2B tails. However, there is
some experimental evidence suggesting that transcription-
al competence of chromatin is also regulated by H2A and
H2B tails, and this is particularly true for H2B tails (8).
Early studies in yeast demonstrated that the deletion of
H2B tails results in a defect in the repression of GAL1 and
PHO5 genes (9,10). Additional support for the repressive
nature of H2B tails came from yeast genome microarray
analysis, showing that the tail deletion of H2B leads to the
upregulation of a large number of genes (11). Moreover,
acetylation of H2B tails appears to be effective at relieving
this H2B tail-derived repression of transcription, as judged
by the derepression of more genes in wild-type yeast
strain, than was observed in strains containing H2B tails
that were mutated at acetylation sites (11).
While these results suggest that the H2B N-terminal tail
is a critical regulator of chromatin function, it is currently
unclear how the tail domain makes a negative contribu-
tion to regulation of gene transcription. One possible
mechanism is that H2B tails would serve as an interaction
domain to bring speciﬁc repressors in close proximity to
gene promoters and establish an inactive state of chroma-
tin. An example to support this possibility is photo-
morphogenesis regulator DET1 in plant cells, which
interacts with unacetylated H2B tails of nucleosomes at
the promoter region and maintains genes in a repressed
state (12). Thus, given that many of the functions of other
histone tails involve tail-factor interactions (5,13), H2B
tails may employ a similar strategy to play a regulatory
role in chromatin transcription.
Related to the current report, p14ARF is a tumor sup-
pressor that controls cellular senescence in response to
oncogenic stresses, being often mutated in many types of
human cancer (14–16). Much of the tumor suppressor
function of p14ARF has been linked to its ability to
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ubiquitination and degradation of p53. The resultant sta-
bilization of p53 leads to increased expression of
p53-responsive genes, thereby inducing cell cycle arrest
and apoptosis (17). However, this paradigm is increasingly
challenged by a substantial number of studies
demonstrating that p14ARF is capable of regulating cell
growth control and apoptosis induction in a
p53-independent manner as well (18–21). Mouse models
without p53, Mdm2 and p19ARF (mouse homolog of
human p14ARF) are much more prone to developing
tumors than mice lacking p53 and Mdm2 but retaining
p19ARF. The reintroduction of p19ARF into mouse
embryo ﬁbroblasts lacking p53, Mdm2 and p19ARF
restored the apoptotic response to a level similar to that
seen in the wild-type cells (22). The new aspect of p14ARF
function was further revealed by the characterization of a
wide range of new p14ARF-interacting proteins, such as
Tip60, B23/nucleophosmin and ARF-BP1 E3 ubiquitin
ligase (23–26). These ﬁndings support the idea that
p14ARF can exert its function in a p53-independent
manner via the interaction with a multitude of different
cellular partners.
In the present study, we combine a series of biochemical
and cellular techniques to investigate the molecular mech-
anisms underlying H2B tail-mediated repression of chro-
matin transcription. We demonstrate that p14ARF
participates in establishing and maintaining a transcrip-
tionally repressive chromatin state through its physical
interaction with H2B tails. This process is accompanied
by HDAC1-mediated deacetylation of H2B–K20, which is
critical for the stable localization and prolonged activity
of p14ARF in target genes. Thus, our results identify
p14ARF as the ﬁrst human non-histone protein interact-
ing with H2B tail and highlight this physical interaction as
a platform to read the chromatin state and establish gene
silencing.
MATERIALS AND METHODS
Cell culture, antibodies and constructs
HeLa cells were cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 10% fetal bovine
serum (FBS). NARF-E6 osteosarcoma cells were main-
tained in DMEM containing 10% FBS, 150mg/ml
hygromycin and 300mg/ml G418. For p14ARF expres-
sion, NARF-E6 cells were treated with 1mM isopropyl-
b-D-thiogalactoside (IPTG). Further details for
antibodies and plasmid constructions are available in the
‘Materials and Methods’ section of Supplementary Data.
Puriﬁcation and mass spectrometric analysis of nH2BIFs
HeLa cell lines expressing human H2B tails were gene-
rated by transfection of pIRES-8xnH2B vector in which
Flag-HA–H2B tails are continuously expressed. Colonies
were selected with G418 (500mg/ml) for 2 weeks and tested
for their stable expression of H2B tails by immunoblot
analysis. Positive cell clones were grown in spinner culture.
Nuclear extracts were prepared as described (27,28).
Ectopic H2B tails and their interacting proteins
were puriﬁed from nuclear extracts (300mg) by sequential
immunoprecipitation using anti-Flag M2 and anti-HA
antibodies (Sigma) in the precipitation buffer (20mM
Tris–HCl, pH 7.3, 300mM KCl, 0.2mM EDTA, 20%
Glycerol and 0.1% NP-40). The puriﬁed proteins were
resolved by 4–20% gradient SDS–PAGE, and stained
with Coomassie blue. Protein bands present in the H2B
tail lane, but not in the control lane were excised and
analyzed by liquid chromatography-tandem mass
spectrometry (LC-MS/MS) at the Mass Spectrometry
and Proteomics Core Facility (University of Southern
California).
Preparation of recombinant proteins
Detailed protocols describing the preparation of recom-
binant proteins are provided in ‘Materials and Methods’
section of Supplementary Data.
Reconstitution of nucleosome arrays and
mononucleosomes
For nucleosome array reconstitution, the pG5ML601-
280G containing 280bp G-less cassettes were digested
with EcoRI and HindIII, and the G5ML601 array DNA
fragments were gel puriﬁed. To reconstitute mononucleo-
somes, the 207bp G5ML and 207bp 601 sequences were
polymerase chain reaction (PCR) ampliﬁed from the
p5GML601-280G and p601-1 plasmids, respectively.
Nucleosome arrays and mononucleosomes were
reconstituted by salt gradient dialysis and puriﬁed by sedi-
mentation in a 5–30% (v/v) glycerol gradient (29,30).
Immunodepletion of p14ARF from nH2BIFs
Immunodepletion was carried out in a 100ml reaction con-
taining 10mg of nH2BIFs and 2mg of control or p14ARF
antibody coupled to 20ml of protein A/G-PLUS agarose
(Santa Cruz Biotechnology). After an overnight incuba-
tion at 4 C under constant rotation, the supernatant was
recovered and analyzed by SDS–PAGE and
immunoblotting.
Transcription and histone acetyl transferase assays
In vitro transcription assays were performed using 100ng
of G5ML601-280G nucleosome arrays for each reaction.
Recombinant p14ARF proteins or nH2BIFs were added
before or after p300 (20ng) and acetyl-CoA (10mM). The
radiolabeled transcripts were resolved on a 5% urea–
PAGE and detected by autoradiography. For nucleosome
histone acetyl transferase (HAT) assays to examine the
effects of lysine mutations, G5ML nucleosomes (200ng)
were pre-incubated with Gal4-VP16 (15ng) for 20min,
and then with p300 (20ng) and acetyl-CoA (10mM) for
60min. HAT reactions were analyzed by autoradiography
or immunoblotting with AcH2A, AcH2B, AcH3 and
AcH4 antibodies.
Protein–protein and protein–nucleosome interaction
studies
Glutathione S-transferase (GST) pull-down assays were
carried out using puriﬁed recombinant GST or
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beads (GE Healthcare) and the indicated recombinants
proteins in 400ml of binding buffer (25mM HEPES, pH
7.8, 0.2mM EDTA, 20% glycerol, 150mM KCl and
0.1% NP-40) for 1.5h at 4 C. Glutathione beads were
washed four times with the binding buffer, and sub-
jected to immunoblot analysis. For nucleosome binding
assays, biotinylated nucleosomes (1mg) were immobilized
on Streptavidin agarose beads (Novagen) and
incubated with recombinant proteins for 16h at 4 C.
After extensive washing with the binding buffer, the
bound proteins were detected by immunoblotting. To
immunoprecipitate p14ARF and HDAC1, whole cell
lysates (1mg) from IPTG-treated NARF-E6 cells were
incubated with anti-p14ARF and anti-HDAC1
antibodies (2mg) at 4 C for 16h. Immune complexes
were recovered using protein A/G-PLUS agarose,
washed four times with binding buffer and analyzed
by immunoblotting.
Microarray and quantitative reverse transcription PCR
Total RNA was isolated from mock- or IPTG-treated
NARF-E6 cells using the TRIzol reagent according to
the manufacturer’s instructions (Invitrogen). Gene expres-
sion microarray experiments were conducted using a
whole-genome expression array (Sentrix Human-6
Expression BeadChip version 3, Illumina) at the
University of Southern California Epigenome Center.
This high density oligonucleotide array chip consists of
about 48000 probe sequences derived from RefSeq genes
and the latest Unigene release (http://www.switchtoi.
com/annotationﬁles.ilmn). Data were processed and
analyzed by using the BeadStudio software (Illumina).
The quantitative reverse transcription PCR (qRT–PCR)
was performed using the iScript cDNA Synthesis
Kit (Bio-Rad) and the IQ SYBR Green Supermix
(Bio-Rad) with an iCycler IQ5 real time cycler
(Bio-Rad). The speciﬁcity of the ampliﬁcation reactions
were monitored by melting curve analysis. The threshold
cycle (Ct) value for each gene was normalized to the Ct
value for GAPDH. All samples were run in triplicate and
results were averaged. The primer sets used for qRT–
PCR are listed in Supplementary Table S1.
Chromatin immunoprecipitation and RNA interference
Chromatin immunoprecipitation (ChIP) assays with
NARF-E6 cells, either treated or not treated with IPTG,
were performed as stated in the Agilent mammalian
ChIP-on-chip protocol and are explained in detail in the
‘Materials and Methods’ section of Supplementary Data.
Antibodies speciﬁc for p14ARF, b-catenin, H2B, H2B
AcK20, AcH3 and AcH4 were used for immunopre-
cipitation. The positions of the PCR primers within the
promoter regions are shown in Figure 5A. All samples
were run in triplicate and results were averaged. For
HDAC1 knockdown experiments, a DNA oligonucleotide
encoding shRNA speciﬁc for HDAC1 mRNA (50-GCAG
ATGCAGAGATTCAAC-30) was subcloned into the
pSUPER.puro (OligoEngine). NARF-E6 cells were stably
transfected with the HDAC1 shRNA expression
construct, and then subjected to qRT–PCR and ChIP
analyses. Primers used for ChIP analysis are listed in
Supplementary Table S2.
RESULTS
H2B tail-interacting factors repress chromatin
transcription
We recently established a protocol that allows puriﬁcation
of factors recognizing N-terminal tails of histones H3 and
H4 (28,31). In the present study, we employed the same
protocol to search for potential H2B tail-binding proteins.
To this end, we generated a cell line that continuously
expresses the ﬁrst 37 amino acids of human H2B fused
to the Flag and HA epitopes (Supplementary Figure
S1A). This N-terminal domain contains the nuclear local-
ization signal (NLS, amino acids 21–33) that mediates
active transport across the nuclear membrane after cyto-
plasmic translation of the tail domains (Supplementary
Figure S1B) (32,33). After two-step puriﬁcation using
anti-Flag and anti-HA immunoafﬁnity chromatographies
(Supplementary Figure S1A), proteins co-puriﬁed with the
H2B tail were resolved by SDS–PAGE and speciﬁc
protein bands were subjected to mass spectrometric ana-
lysis. As summarized in Figure 1A, our analysis revealed
eight proteins that have never been described in associ-
ation with H2B tails. The mass spectrometry data were
further validated by immunoblot analysis using available
antibodies (Figure 1B). Since ectopic H2B tails could
undergo acetylation, methylation and phosphorylation
via actions of cellular modifying activities, we checked
the modiﬁcation status of the ectopic tails by immunoblot
analysis. However, our analyses using antibodies speciﬁc
for acetylations at K5, K12, K15 and K20, phosphoryl-
ation at S14 and methylations at K5 and K11 showed no
detectable modiﬁcation of ectopic H2B tails (data not
shown).
To functionally characterize H2B tail-interacting factors
(nH2BIFs), we next assessed the ability of the puriﬁed fac-
tors to regulate transcription from chromatin. Nucleosome
arrays were reconstituted onto the linear G5ML601 DNA
fragment containing Gal4 binding sites linked to the
adenovirus major late core promoter proceeding 280bp
G-less cassette and, on both sides, seven direct repeats
of the 207bp 601 nucleosome positioning sequence
(Supplementary Figure S2A). The successful reconstitu-
tion of nucleosome arrays using bacterially expressed his-
tone octamers was conﬁrmed by partial micrococcal
nuclease (MNase) digestion as previously described
(Supplementary Figure S2B) (34). Transcription assays
with nucleosome arrays were carried out with Gal4-
VP16 activator and p300 HAT as summarized in
Supplementary Figure S2A. Given the fact that, the add-
ition or removal of acetyl groups on histones inﬂuences
the ability of factors to bind to the nucleosome (5,28), we
assessed the effect of p14ARF on chromatin transcription
before and after p300 acetylation reactions. As previously
reported (35,36), transcription from nucleosome arrays
was completely dependent on Gal4-VP16, p300, and
acetyl-CoA (Figure 1C, lanes 1–3 and 6–8). When the
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tion was signiﬁcantly repressed by the addition of the
factors prior to p300 (lane 5). In contrast, no detectable
change in chromatin transcription was observed upon the
addition of the puriﬁed factors after p300 (lane 10). Due to
addition of the same amount of heat-inactivated factors
(HI-nH2BIFs) to our reactions had no effect on chroma-
tin transcription (lanes 4 and 9), the observed repression is
unlikely from non-speciﬁc interference in the transcription
reaction.
p14ARF among nH2BIFs is responsible for the repression
To deﬁne the key factors directly involved in this repres-
sion process, we decided to evaluate the effects of indi-
vidual factors on chromatin transcription by using
recombinant proteins. Thus, nH2BIFs were expressed in
insect cells (for ARF-BP1) or in bacteria (for hnRNP-U,
HDAC1, hnRNP-K, hnRNP-H1, B23, RPL5 and
p14ARF) as described in the ‘Materials and Methods’
section. After afﬁnity tag-based puriﬁcation of the recom-
binant factors, their purity was conﬁrmed by SDS–PAGE
Figure 1. Repression of chromatin transcription by p14ARF. (A) Afﬁnity puriﬁcation of nH2BIFs. Flag-HA-tagged H2B tails were stably expressed
in HeLa cells and subjected to sequential immunoprecipitations utilizing anti-Flag and anti-HA antibodies. The co-puriﬁed proteins were separated
by 4–20% gradient SDS–PAGE and identiﬁed by liquid chromatography–tandem mass spectrometry (LC–MS/MS). The positions of the molecular
mass markers (in kDa) are indicated on the left. Lane 1, mock-puriﬁed control; lane 2, nH2BIFs (H2B tail-interacting factors). (B) Immunoblot
analysis of the puriﬁed nH2BIFs. The puriﬁed nH2BIFs were separated by 4–20% gradient SDS–PAGE and analyzed by immunoblotting with the
indicated antibodies. Lane 1, nuclear extract input; lane 2, mock-puriﬁed control; lane 3, nH2BIFs. (C) Effects of the puriﬁed nH2BIFs on chromatin
transcription. Reconstituted nucleosome arrays were transcribed in the presence of Gal4-VP16 (15ng), p300 (20ng), acetyl-CoA (10mM) and/or
nH2BIFs (15ng) as summarized in Supplementary Figure S2A. The puriﬁed nH2BIFs were added before or after p300-mediated chromatin acetyl-
ation as indicated. Radiolabeled transcripts were resolved on a 5% PAGE containing 7 M urea and detected by autoradiography. Heat-inactivated
tail-interacting factors (HI-nH2BIFs) were used in control reactions, and the results shown are representative of three independent experiments.
(D) Effects of the recombinant nH2BIFs on chromatin transcription. Transcription reactions with G5ML601 nucleosome arrays were essentially as
described in Figure 1C, but nH2BIFs were replaced by the indicated recombinant factors. Each of recombinant nH2BIFs was added prior to p300.
(E) Loss of p14ARF activity upon pre-acetylation of chromatin. Transcription assays were performed under the conditions described in the legend to
Figure 1D, but p14ARF was added before (lanes 1–5) or after (lanes 6–10) p300 acetylation reactions. (F) Depletion of p14ARF from the puriﬁed
nH2BIFs. The puriﬁed nH2BIFs were immunodepleted of p14ARF as described in the ‘Materials and Methods’ section. To conﬁrm that the puriﬁed
factors had been depleted of p14ARF, mock- and p14ARF-depletion reactions were analyzed by Coomassie blue staining (lanes 1–3) and immuno-
blotting (lanes 4–6). (G) Effects of the p14ARF-depleted nH2BIFs on chromatin transcription. In vitro transcription was conducted as described in
Figure 1D, except that mock-depleted (lane 4) or p14ARF-depleted (lanes 5–9) nH2BIFs were used as indicated. The p14ARF-depleted nH2BIFs
were supplemented with either recombinant B23 (lane 8) or p14ARF (lane 9). Heat-inactivated (HI) B23 and p14ARF were used in control reactions
(lanes 6 and 7).
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assays were performed with each of these factors, no de-
tectable repression in chromatin transcription was
observed by the addition of ARF-BP1, hnRNP-U,
HDAC1, hnRNP-K, hnRNP-H1, B23 or RPL5 prior to
p300 (Figure 1D, lanes 5, 10, 15, 20, 25, 30 and 40).
However, the addition of p14ARF prior to p300 resulted
in a dramatically lower level of transcription (lane 35),
strongly supporting that p14ARF is mainly responsible
for the repressive effects of nH2BIFs. As expected, no
measurable effect of p14ARF was observed when
p14ARF was added to transcription reactions after p300
(Figure 1E, lane 5 versus lane 10), suggesting that
pre-acetylation of chromatin mediated by p300 prevents
the repressive action of p14ARF. It is worth noting that,
the advantage of using recombinant histones over their
native counterparts in chromatin reconstitution is to
exclude the effects of pre-existing acetylation of native
histones (Supplementary Figure S4A); chromatin tem-
plates reconstituted with native histones were immune to
inhibitory effects of p14ARF (Supplementary Figure S4B,
lane 5 versus lane 10).
To further conﬁrm the above results, the fraction con-
taining p14ARF was removed from the puriﬁed nH2BIFs
by treatment with anti-p14ARF antibody. The SDS–
PAGE analysis of p14ARF antibody-treated factors
showed almost complete disappearance of the 14kDa
band (Figure 1F, lane 3 versus lanes 1 and 2), indicating
a speciﬁc depletion of p14ARF from the unfractionated
nH2BIFs. A minor reduction of B23 in the depleted
nH2BIFs was also observed after p14ARF depletion, pos-
sibly due to its partial interaction and thus co-depletion
with p14ARF (lanes 1–3). Immunoblot analysis further
conﬁrmed that p14ARF was efﬁciently removed from
the puriﬁed nH2BIFs (Figure 1F, lanes 4–6). As
expected, when the p14ARF-depleted nH2BIFs were
tested in chromatin transcription, no apparent repression
of transcription was observed (Figure 1G, lane 5 versus
lane 3). The addition of recombinant p14ARF, but not its
heat-inactivated form, to the depleted nH2BIFs resulted in
the repression of chromatin transcription (Figure 1G, lane
9 versus lane 7). In contrast, the depleted nH2BIFs sup-
plemented with recombinant B23 failed to show any
change in transcription (Figure 1G, lane 8), further con-
ﬁrming that the p14ARF among nH2BIFs plays a major
role in repressing chromatin transcription.
The interaction between p14ARF and H2B tail is
required for transcriptional repression
As p14ARF was co-puriﬁed with free H2B tails, the tran-
scription results we obtained thus far, suggest that
p14ARF inhibits chromatin transcription by interacting
with unacetylated H2B tails associated with promoter-
encompassing nucleosomes. To gain support for this
idea, we examined the interaction of Flag-p14ARF with
equimolar amounts of GST-histone tail fusion proteins
immobilized on glutathione-Sepharose beads. As con-
ﬁrmed by immunoblot analysis of the binding reactions,
p14ARF interaction was highly selective for GST-H2B
tails (Figure 2A). In similar binding experiments with
truncated versions of H2B tails, p14ARF efﬁciently binds
to three H2B tail deletion mutants lacking the ﬁrst 3, 9 or
15 amino acids, but not to another tail mutant lacking the
ﬁrst 26 amino acids (Figure 2B). To further characterize
the interaction between H2B tail and p14ARF, we re-
constituted nucleosomes containing wild-type H2B or
H2B N-terminal deletion mutants on a 601 nucleosome
positioning sequence (Supplementary Figure S5A) and
checked the binding of p14ARF. In agreement with the
interactions observed with GST-H2B tails, we detected a
remarkable binding preference of p14ARF for the im-
mobilized nucleosome containing intact H2B or H2B
mutant lacking the ﬁrst 15 amino acids over the nucleo-
some containing H2B mutant lacking the ﬁrst 26 amino
acids (Figure 2C). To conﬁrm these results, we repeated
in vitro binding experiments using GST-nH2B 16–26 and
nucleosomes containing H2B 16–26. Our results show
that the ability of p14ARF to bind H2B tails and nucleo-
somes is signiﬁcantly compromised when amino acids
16–26 of H2B tail domain were deleted (Supplementary
Figure S6). Additionally, in mapping the interaction
region of p14ARF, we found that N-terminal domain
(residues 1–64) of p14ARF retained strong afﬁnity for
GST-H2B tail, whereas, no apparent interaction was
observed with the remainder (residues 65–132) of the
protein (Figure 2E and Supplementary Figure S5B).
Similar results were obtained when nucleosomes were
reconstituted on the 601 nucleosome positioning
sequence and used to study the binding properties of
p14ARF deletion mutants (Figure 2F). These results
argue strongly against the possibility that the observed
binding of p14ARF to H2B tail is due to their non-speciﬁc
associations.
Having found that residues 16–26 of H2B interact with
N-terminal domain of p14ARF, we next assessed whether
this interaction is critical for p14ARF-induced tran-
scriptional repression. The use of recombinant histones
for chromatin reconstitution allowed us to make dele-
tions or point mutations in the histone tail regions that
could inﬂuence p14ARF-induced repression. Consistent
with the previous ﬁnding that H3 and H4 tails are sufﬁ-
cient for p300-mediated chromatin transcription (37),
deletion of the ﬁrst 26 amino acids of H2B showed
minimal effects on transcription stimulatory activity of
p300 (Figure 2D, lane 13 versus lane 3). In parallel tran-
scription experiments with p14ARF, deletion of the ﬁrst
15 amino acids of H2B did not cause any change in the
ability of p14ARF to repress chromatin transcription
(lane 10 versus lane 5). However, further truncation of
H2B up to amino acid 26 overtly interfered with the re-
pressive action of p14ARF on chromatin transcription
(lane 15 versus lane 5). These results conﬁrm that
p14ARF-mediated repression of chromatin transcription
is highly dependent on a small subdomain in the H2B tail,
comprised of residues 16–26. In checking the effects of
N-terminal domain (residues 1–64) and the remainder
(residues 65–132) of p14ARF on transcription reactions,
we found that the N-terminal domain can repress chroma-
tin transcription to the same extent as the full-length
p14ARF (Figure 2G, lane 9 versus lane 5). In contrast,
chromatin transcription was not repressed when the
Nucleic Acids Research, 2011,Vol.39, No. 21 9171C-terminal fragment of p14ARF was added to the
reaction (lane 7 versus lane 5).
p14ARF suppresses multiple cell cycle regulatory genes
The observation that p14ARF–H2B tail interaction is
required for chromatin repression, suggests that this
might be responsible for the p53-independent action of
p14ARF. To identify genes whose expression is regulated
by this mechanism, we examined gene expression proﬁles
using NARF-E6, a p53-null osteosarcoma cell line, which
expresses p14ARF from an IPTG-inducible promoter
(Supplementary Figure S7A) (38). Western blotting of
cytoplasmic and nuclear fractions conﬁrmed that the
Figure 2. Mapping of the H2B and p14ARF interaction domains. (A) Preferential binding of p14ARF to H2B tail. Interaction of 14ARF with
histone tails was examined by GST pull-down assays using GST (lane 2) or GST–histone tail fusions (lanes 3–6), and the binding reactions were
analyzed by immunoblotting and Coomassie brilliant blue (CBB) staining. Lane 1 contains 50% of the input p14ARF. (B) p14ARF interaction with
H2B tail deletion mutants. The left panel shows the schematic illustration of H2B tail and its deletion mutants. Numbers indicate amino acid
residues. The right panel shows the detection of Flag-p14ARF in GST-pull down assays with GST (lane 2) or GST-H2B tail deletion mutants (lanes
3–7). (C) p14ARF interaction with H2B tail-deleted nucleosomes. Nucleosomes containing wild-type or tailless H2B were reconstituted on
biotinylated 207bp 601 fragments and immobilized on Streptavidin agarose beads. The binding assays were performed with Flag-p14ARF, and
the presence of p14ARF in the beads was analyzed by immunoblotting with anti-Flag antibody. (D) Impairment of p14ARF-induced chromatin
repression by H2B tail deletions. In vitro transcription experiments were performed as described in Figure 1D, but with chromatin templates
containing H2B N-terminal deletion mutants. (E) H2B tail interaction with p14ARF deletion mutants. The top panel shows the schematic illustration
of p14ARF deletion mutants. The bottom panel shows the detection of p14ARF deletion mutants in GST pull-down assay with GST–H2B tail.
Numbers indicate amino acid residues. Input lanes 1–3 represent 25% of p14ARF used in the binding reactions. (F) Nucleosome interaction with
p14ARF deletion mutants. Nucleosomes containing wild-type H2B were reconstituted on biotinylated 207bp 601 sequences and immobilized on
Streptavidin agarose beads. The binding assays were performed with Flag-p14ARF deletion mutants, and the presence of p14ARF deletion mutants
in the beads was analyzed by immunoblotting with anti-Flag antibody. (G) Effects of N- and C-terminal regions of p14ARF on chromatin tran-
scription. Transcription reactions were essentially as described in Figure 1D, but contained p14ARF deletion mutants. Heat-treated (HI) p14ARF
proteins were also tested in control reactions.
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nucleus after its expression (Supplementary Figure S7C).
RNA was extracted and labeled from cells grown in the
absence or presence of IPTG for 48h, and was hybridized
to the Illumina microarrays. Statistical analysis identiﬁed
a total of 330 genes to be downregulated and 20 genes to
be upregulated with a 2-fold change cutoff in response
to p14ARF expression (Figure 3A and Supplementary
Table S3). Among the genes downregulated by p14ARF,
the most signiﬁcant repression was observed for genes that
are involved in cell cycle control and apoptosis. qRT–PCR
was performed on the ﬁve genes that were repressed
(AKT1, Cyclin E1, CHD5 and eIF4E3) or unchanged
(RUNX2) in our microarray studies and the results were
consistent with the microarray results (Figure 3B).
As p14ARF selectively interacts with H2B tails
protruding from the nucleosome, it is possible that free
H2B tails might inﬂuence the repressive activities of
p14ARF on its target nucleosomes through competing
for binding with p14ARF. To test this, we expressed the
N-terminal tail domains of human histones and checked
their effects on transcription of the ﬁve selected genes after
IPTG treatment. As expected, our western blot analysis
conﬁrmed that all ectopic histone tails are predominantly
located in the cell nucleus after their expression
(Supplementary Figure S7B and S7C). Expression of the
H2B tail led to a dramatic enhancement in transcription of
the four target genes (AKT1, Cyclin E1, CHD5 and
eIF4E3), but only a modest increase in transcription of
the control gene (RUNX2) (Figure 3C, +p14ARF/nH2B
versus +p14ARF/Con). The observed effects of ectopic
H2B tails were speciﬁc, since other histone tails
produced a slight or no detectable change in transcription
of the selected genes (Figure 3C). The inability of the H2B
tails to affect transcription in the absence of p14ARF
further conﬁrmed that the observed enhancement was
due to the sequestration of p14ARF activity ( p14ARF/
nH2B versus  p14ARF/Con). To gain more support for
the competition results above, we also checked whether
H2B tail expression targeting p14ARF is directly attribut-
able to alteration in cell proliferation. As summarized in
Figure 3D, overexpression of H2B tails resulted in a sharp
increment in the proliferation of p14ARF-expressing cells,
but no detectable change in control cells.
H2B–K20 acetylation interferes with the repressive
action of p14ARF
One of the key observations made in our experiments so
far is that p300-mediated pre-acetylation of H2B tails elim-
inates the action of p14ARF as a negative regulator of
chromatin transcription (Figure 1E). To determine which
of the acetylation sites in H2B is important in blocking the
p14ARF activity, we prepared a series of chromatin tem-
plates in which four major acetylation sites (K5, K12, K15
and K20) of H2B were mutated individually or in com-
bination (Supplementary Figure S8A). As expected, no de-
tectable change in chromatin transcription was observed
by the addition of p14ARF after p300-mediated acetyl-
ation of chromatin (Figure 4A, lane 5). Similarly,
neither the individual mutation of K5, nor the
simultaneous mutation of K12 and K15 in H2B prevented
p300-mediated acetylation from blocking the action of
p14ARF (lanes 10 and 15). Surprisingly, however,
p14ARF was capable of repressing transcription from
chromatin-carrying K20-mutated H2B, when p14ARF
was added after the p300-mediated acetylation reaction
(lane 20). Likewise, the repressive effect of p14ARF on
pre-acetylated chromatin was also rescued by simultan-
eous mutation of all four acetylation sites (K5, K12,
K15 and K20) of H2B (lane 25), further underscoring
the prominent role of K20 acetylation in antagonizing
the repressive action of p14ARF.
To explore the molecular basis for the transcription
results described above, we conducted in vitro binding
assays with pre-acetylated GST fusion proteins containing
wild-type or lysine-mutated forms of H2B tails. As
expected, pre-acetylation of wild-type H2B tails by p300
reduced p14ARF binding (Figure 4B, lane 5 versus lane
4). However, parallel binding experiments with K20- or
K5-, 12-, 15-, 20-mutated H2B tails showed a similar
binding with p14ARF regardless of pre-incubation with
p300 and acetyl-CoA (lanes 6–9). We also found that
p300-mediated pre-acetylation reduced the binding afﬁnity
of p14ARF to nucleosomes containing wild-type H2B, but
did not change p14ARF interaction with nucleosomes
containing K20- or all four acetylation site-mutated
H2B (Figure 4C and Supplementary Figure S8B).
Hence, these results establish H2B–K20 acetylation as a
major regulatory mark, and ﬁt well with the transcription
data showing that pre-acetylation of H2B–K20 is sufﬁ-
cient to block the inhibitory action of p14ARF in chro-
matin transcription.
p14ARF occupancy at AKT1 promoter coincides with
H2B–K20 deacetylation
Among the p14ARF-regulated genes identiﬁed through
microarray analysis, AKT1 is of particular interest, as
the overexpression of this gene was recently found to be
an early event in carcinogenesis (39). To elucidate a
possible role of p14ARF in the regulation of AKT1 tran-
scription, we established a high resolution ChIP protocol
that allows us to map factor occupancy and histone modi-
ﬁcation on the AKT1 locus. As depicted in Figure 5A, the
four different promoter regions (amplicons  1337,  941,
 670 and  398), transcription start site (amplicon 20) and
two different coding regions (amplicons 224 and 470) of
the AKT1 gene were ampliﬁed for quantiﬁcation of the
ChIP-enriched DNA. In conﬁrmation of our microarray
results, the IPTG-induced expression of p14ARF led to a
stable localization of p14ARF at amplicon  398 of the
AKT1 (Figure 5B, p14ARF). Also, consistent with our
results indicating a selective association of p14ARF with
K20-deacetylated H2B, parallel ChIP experiments showed
a dramatic reduction of H2B–K20 acetylation at  398 of
the AKT1 promoter (H2B AcK20). As there were little or
no change in H3 and H4 acetylation (AcH3 and AcH4) at
all regions, these results constitute a powerful argument
that the observed repression of AKT1 transcription by
p14ARF is mainly contributed by deacetylated H2B–
K20. Furthermore, a very similar distribution of H2B
Nucleic Acids Research, 2011,Vol.39, No. 21 9173Figure 3. Suppression of multiple genes by p14ARF. (A) Global analysis of p14ARF-dependent gene regulation. Dots in the two-dimensional
scatter-plot represent expression values for the genes with a change >2-fold in either of two independent analyses (Batch #1 and Batch #2).
These analyses identiﬁed 330 genes that were downregulated (indicated by white dots) and 20 genes that were upregulated (indicated by black
dots) in the IPTG-treated cells, compared with the mock-treated cells. (B) Validation of microarray data. The RNA samples from mock-treated (-
p14ARF) or IPTG-treated (+p14ARF) NARF-E6 cells were subjected to qRT–PCR to examine the expression levels of AKT1, Cyclin E1, CHD5,
eIF4E3 and RUNX2 genes. All expression levels were normalized to that of GAPDH, and average and standard deviation of three independent
experiments are shown. (C) Inhibition of p14ARF-mediated repression by ectopic H2B tails. NARF-E6 cells were transfected with an empty vector
(Con) or vectors expressing H2B tails (nH2B), H2A tail (nH2A), H3 tails (nH3) or H4 tail (nH4) for 24h and were further mock-treated (-p14ARF)
or treated with 1mM IPTG (+p14ARF) for 48h. Changes in transcription of AKT1, Cyclin E1, CHD5, eIF4E3 and RUNX2 genes were measured by
qRT–PCR (right panel). (D) Attenuation of p14ARF-enhanced cell proliferation by ectopic H2B tails. NARF-E6 cells were treated as in Figure 3C,
and cell viability was measured by trypan blue staining analysis. All reactions were performed in triplicate.
9174 Nucleic Acids Research, 2011,Vol.39, No. 21was seen in control and p14ARF-expressing cells (H2B),
making it highly unlikely that the decrease in K20 acetyl-
ation is a result of H2B dissociation from nucleosomes. To
explore the possible effect of p14ARF on other target
genes, we repeated ChIP experiments at the Cycline E1
locus; similar results were obtained from these parallel
experiments (Supplementary Figure S9).
Since b-catenin has a regulatory function in AKT1 gene
transactivation (40), promoter localization of b-catenin
was also determined. b-Catenin showed a similar pattern
of localization at the AKT1 promoter regions compared to
p14ARF (Figure 5B; compare b-catenin with p14ARF).
However, because b-catenin showed the same occupancy
proﬁles without p14ARF expression, p14ARF does not
seem to affect b-catenin localization at the AKT1
promoter. Rather, the fact that p14ARF has no distin-
guishable DNA binding motif suggests that p14ARF
may be initially recruited by b-catenin. To check this pos-
sibility, Flag-p14ARF was incubated with GST-b-catenin
immobilized on glutathione-Sepharose beads, and
p14ARF binding was analyzed by immunoblotting.
p14ARF was precipitated from the reaction by
GST-b-catenin, but GST control failed to show any de-
tectable precipitation of p14ARF under the same condi-
tions (Figure 5C). The interaction of p14ARF with
b-catenin in physiological conditions was further tested by
immunoblot analysis of anti-p14ARF immunoprecipitates
from lysates of p14ARF-induced NARF-E6 cells. As
shown in Figure 5D, b-catenin co-immunoprecipitated
with p14ARF. A reverse co-immunoprecipitation experi-
ment in which immunoprecipitation was carried out using
anti-b-catenin antibody also showed that p14ARF
co-immunoprecipitated with b-catenin (Figure 5D). The
interaction between p14ARF and b-catenin is speciﬁc, as
they showed no detectable binding to HMGB1 control in
the precipitated complex (a-HMGB1). It thus seems that,
although other factors may be involved, the initial recruit-
ment of p14ARF at the AKT1 promoter reﬂects its direct
interaction with b-catenin.
p14ARF cooperates with HDAC1 to repress transcription
Although the inhibitory action of p14ARF in chromatin
transcription reﬂects its direct interaction with
Figure 4. Regulation of p14ARF function by H2B–K20 acetylation. (A) Antagonistic effects of H2B–K20 acetylation on p14ARF transcriptional
repression. Transcription assays were performed as in Figure 1D, but p300 was added to the reactions before p14ARF. Chromatin templates contain
wild-type (WT) (lanes 1–5) or lysine-mutated (K5R, K12, 15R, K20R and K5, 12, 15, 20R) (lanes 6–25) H2B proteins. (B) Antagonistic effects of
K20 acetylation on H2B tail–p14ARF interaction. Flag-tagged p14ARF was tested for binding to GST (lanes 2 and 3) or GST-fused wild-type (WT)
or lysine-mutated (K5R, K12,15R, K20R and K5,12,15,20R) H2B tails (lanes 4–9). Lane 1 shows 25% of p14ARF used in the binding reactions.
Experiments were repeated three times with comparable results. Data were quantitated by phosphoimager analysis. (C) Antagonistic effects of H2B–
K20 acetylation on nucleosome-p14ARF interaction. Mononucleosomes containing wild-type (WT) or mutant (K20R and K5,12,15,20R) H2B were
reconstituted on biotinylated 207bp G5ML fragments and immobilized on Streptavidin agarose beads. Flag-tagged p14ARF was incubated with the
nucleosomes containing wild-type (lanes 1 and 2) or mutant (lanes 3–6) H2B, and p14ARF binding was determined by immunoblot analysis using
anti-Flag antibody. Data were quantitated by phosphoimager analysis, and similar results were obtained in two independent binding experiments.
Nucleic Acids Research, 2011,Vol.39, No. 21 9175unacetylated H2B tails, it is not clear which factors are
mainly responsible for establishing and maintaining the
unacetylated state of H2B tails. Given the fact that
HDAC1 is co-puriﬁed with ectopic H2B tails (Figure 1A
and B), we next sought to explore whether HDAC1 is
functionally connected to the H2B tail-dependent action
of p14ARF. As ﬁrst conﬁrmed by immunoblot analysis,
transfection of NARF-E6 cells with shRNA targeting
HDAC1 efﬁciently depleted HDAC1 (Figure 6A). In
checking the transcription of the ﬁve selected genes by
Figure 5. Reciprocal localization of p14ARF and H2B–K20 acetylation at a target promoter. (A) A schematic diagram showing the PCR amplicons
used at the AKT1 gene. The numbers indicate the position of the central base pair of the products relative to the transcription start site. (B) ChIP
scanning of p14ARF, H2B AcK20, H2B, AcH3, AcH4 and b-catenin at the AKT1 locus. NARF-E6 cells were mock- or IPTG treated, and analyzed
by quantitative chromatin immunoprecipitation (ChIP) using antibodies speciﬁcally recognizing p14ARF, H2B AcK20, H2B, AcH3, AcH4 and
b-catenin and IgG control. Immunoprecipitated DNA was ampliﬁed by quantitative PCR (qPCR) with primers depicted in Figure 5A and listed in
Supplementary Table S2. Percentage input is determined as the amount of immunoprecipitated DNA relative to input DNA. Error bars represent
standard deviation of three independent experiments. (C) p14ARF interaction with b-catenin in vitro. Flag-tagged p14ARF was tested for binding to
GST (lane 2) or GST-b-catenin fusion (lane 3) proteins. p14ARF interaction was determined by immunoblot analysis using anti-Flag antibody. Lane
1 represents 10% of p14ARF used in the binding reactions. (D) p14ARF interaction with b-catenin in vivo. NARF-E6 cells were treated for 48h with
1mM IPTG to express p14ARF. Whole cell lysates were prepared and immunoprecipitated with anti-p14ARF (lanes 1–3) or anti-b-catenin (lanes
4–6) antibody, and subjected to immunoblot analysis with anti-p14ARF, anti-b-catenin and anti-HMGB1 antibodies. Input represents 10% of the
cell extracts used in immunoprecipitation.
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substantial reactivation of the four target genes (AKT1,
Cyclin E1, CHD5 and eIF4E3) in p14ARF-expressing
cells, but little or no effect on the control gene (RUNX2)
(Figure 6B). Due to the cooperative action of HDAC1 at
p14ARF, target genes might reﬂect its direct association with
p14ARF or unacetylated H2B, we conducted a series of
interaction studies. In vitro experiments with GST-HDAC1
and Flag-p14ARF reveal that p14ARF directly interacts
with HDAC1 (Figure 6C, lane 3). In contrast, similar
binding experiments with free H2B failed to show any
detectable binding to GST-HDAC1 (lane 6). Consistent
with in vitro binding data, immunoblot analysis of
HDAC1 immunoprecipitates from extracts of the
IPTG-treated NARF-E6 cells, showed a strong inter-
action with p14ARF (Figure 6D, lane 3). Since HDAC1
can directly associate with p14ARF, a possible explan-
ation for the higher level of transcription after HDAC1
knockdown could be the increased acetylation of H2B–
K20 at promoter regions, upon which p14ARF exerts
minimal repressive effects on transcription. Predictably,
when ChIP experiments were performed at the AKT1
Figure 6. Cooperative action of p14ARF and HDAC1 in gene repression. (A) Stable depletion of HDAC1. NARF-E6 cells were stably transfected
with control shRNA (lane 1) or HDAC1 shRNA (lane 2), and the depletion of HDAC1 was analyzed by qRT–PCR (left panel) and immunoblotting
(right panel). (B) Requirement of HDAC1 for p14ARF-mediated repression. Mock-depleted or HDAC1-depleted cells were treated with 1mM IPTG
for 48 h, and mRNA levels of AKT1, Cyclin E1, CHD5, eIF4E3 and RUNX2 were analyzed by qRT–PCR. All reactions were performed in triplicate.
(C) HDAC1 interaction with p14ARF in vitro. GST or GST-fused HDAC1 was incubated with Flag-tagged p14ARF or untagged H2B, and bound
proteins were analyzed by immunoblotting using anti-Flag and anti-H2B antibodies as indicated. Lanes 1 and 4 represent 50% of p14ARF and 20%
of H2B used in the binding reactions, respectively. (D) HDAC1 interaction with p14ARF in vivo. Whole cell extracts were prepared from
IPTG-treated NARF-E6 cells and immunoprecipitated with anti-HDAC1 antibody. The precipitates were analyzed by immunoblotting with
HDAC1 and p14ARF antibodies as indicated. Asterisks indicate non-speciﬁc bands containing IgG heavy chain (lanes 2 and 3). Lane 1 represents
10% of the input. (E) HDAC1-dependent localization of p14ARF at the AKT1 promoter. Mock-depleted and HDAC1-depleted cells were treated
with 1mM IPTG to express p14ARF as in Figure 6B, and ChIP assays of the AKT1 gene were performed using antibodies against p14ARF, H2B
AcK20 and H2B. Input DNA and immunoprecipitated DNA were quantiﬁed by qPCR analysis as described in Figure 5A.
Nucleic Acids Research, 2011,Vol.39, No. 21 9177promoter region in p14ARF-expressing cells, HDAC1
knockdown led to a dramatic increase in H2B–K20 acetyl-
ation and a near complete loss of p14ARF at amplicon
 398 of the AKT1 promoter (Figure 6E, p14ARF and
H2B AcK20). There was a comparable distribution of
H2B over the AKT1 promoter (H2B) in mock and
HDAC1-depleted cells, indicating that ChIP results were
not due to non-speciﬁc crosslinking or nucleosome
aggregation.
DISCUSSION
The regulatory effects of chromatin have been studied
with much greater attention to H3 and H4 N-terminal
tails, but H2A and H2B tails are also implicated in the
regulation of chromatin function (8). Genome-wide ex-
pression proﬁling of yeast strains indicates that the dele-
tion of H2B tails upregulates a large number of genes (11),
suggesting a general repressive effect of the H2B tail
domain in transcription. Despite this distinct role of
H2B tails in transcription, the molecular mechanism
underlying this process has been unclear, partly because
of a lack of understanding of upstream regulatory factors
that contribute to the observed trans-repression potential
of H2B tails. In this report, we demonstrate that p14ARF,
a critical human tumor suppressor, binds to the H2B tails
and functions as a negative regulator of gene
transcription.
A key question that this study presages is whether gene
regulation by H2B tails is through the binding of speciﬁc
chromatin factors to H2B tails. Our initial puriﬁcation
and transcription studies indicate that H2B tails are phys-
ically associated with eight factors, which can signiﬁcantly
repress chromatin transcription. In screening factors re-
sponsible for the observed repression, p14ARF is found
to antagonize transcription from chromatin, when it is
added to chromatin prior to p300 HAT. Furthermore,
much to our surprise, our results reveal a direct link
between the unacetylated state of H2B–K20 and the re-
pressive property of p14ARF. As a potential mechanism
explaining why deacetylation of H2B–K20 is critical for
p14ARF action, we demonstrate that the p14ARF
N-terminal domain selectively interacts with K20-
unacetylated H2B tails. These results point to a previously
unrecognized contribution of H2B–K20 to the control of
gene transcription, through its effect on p14ARF-induced
changes in chromatin competence. Gene regulatory
factors that affect transcription are generally unable to
access their target nucleosomes, so a local remodeling of
nucleosomes is a prerequisite for their activity (41,42).
However, p14ARF does not appear to require prior dis-
ruption of the nucleosome, as we have observed that
p14ARF can directly access unacetylated H2B tails in
the nucleosome. Thus, apart from our demonstration of
repressor activity of p14ARF, these results bear an im-
portant implication on the accessibility of H2B tails for
the establishment of repressed state of chromatin. In many
Figure 7. Model for the role of p14ARF in chromatin silencing. p14ARF recognizes unacetylated H2B tails at target promoters, and acts as a
molecular rheostat to block transcription. For the most efﬁcient repression, p14ARF cooperates with HDAC1 to remove H2B acetylation. Upon
p14ARF dissociation, HAT acetylates H2B tails to establish active chromatin environment and to achieve transcription initiation. See the
‘Discussion’ section for further details.
9178 Nucleic Acids Research, 2011,Vol.39, No. 21cases, distinct tertiary structures are known to be involved
in protein–histone tail interactions, and histone tails
acquire distinct features of recognition as a consequence
of post-translational modiﬁcations (4,43). However, our
sequence alignment and motif prediction fail to detect
any known histone tail binding motifs in p14ARF.
Whether H2B tails recognize a previously undocumented
binding motif in p14ARF is an intriguing question that
needs to be addressed in future studies.
In accord with our in vitro results, our gene expression
proﬁling revealed that p14ARF downregulates 330 genes,
many of which are involved in cell cycle control and apop-
tosis. The repressive role of p14ARF is further
underscored by ChIP and RNAi analyses demonstrating
that p14ARF is speciﬁcally localized at promoter nucleo-
somes containing K20-hypoacetylated H2B to block tran-
scription. As HDAC1 is co-puriﬁed with ectopic H2B
tails, we reasoned that HDAC1 might contribute to
promoter localization of p14ARF by removing and/or
preventing H2B acetylation. Indeed, HDAC1 depletion
increased H2B–K20 acetylation and decreased p14ARF
occupancy at the promoter, placing HDAC1 as a key regu-
lator of p14ARF activity. Interestingly, however, our
ChIP analysis failed to show continuous localization of
HDAC1 over promoter-proximal nucleosomes (data not
shown), implicating transient action of HDAC1 at AKT1
promoter. In this case, HDAC1-mediated deacetylation of
H2B should be categorized as an initial regulator for
p14ARF interaction with nucleosome. Mechanistically,
these aspects of functional interactions between p14ARF
and HDAC1 appear to be critical for H2B tail-mediated
repression, as misregulation of H2B–K20 deacetylation
and thus H2B tail–p14ARF interaction can lead to in-
appropriate gene repression. Since our analyses have
been restricted to the effect of H2B acetylation, future
studies should determine the extent to which the
p14ARF–H2B interaction is regulated by other histone
modiﬁcations such as H2B–S14 phosphorylation (44).
Based on the functional relationship and biochemical
characteristics, we have established for H2B tail,
p14ARF and HDAC1, we propose the following model
of transcriptional repression (Figure 7D). The nuclear
p14ARF–HDAC1 complex is brought to target genes by
interaction with speciﬁc transcription factors (TFs) at the
initial stage of gene repression. After their localization at
promoter regions, HDAC1 removes acetylation of H2B–
K20, mostly over promoter-proximal nucleosomes. This
unacetylated H2B–K20 serves as a binding platform for
p14ARF, thereby enabling p14ARF to maintain a repres-
sive state of nucleosomes at its target genes. This model
implies that HDAC1 recruitment and H2B deacetylation
are the rate-limiting steps for the repressive action of
p14ARF. This model also has implications for H2B
tail-dependent transcriptional activation, because H2B
acetylation will antagonize tethering of p14ARF to the
promoter.
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